ABSTRACT
The circulation of SARS-CoV-2 in Italy has been dominated by two large clusters of outbreaks in Northern part of the peninsula, source of alarming and prolonged infections in Lombardy region, in Codogno and Bergamo areas especially.
The aim of the study was to expand understanding on the circulation of SARS-CoV-2 in the affected Lombardy areas. To this purpose, twenty full length genomes were collected from patients addressing to several Lombard hospitals from February 20th to April 4th, 2020.
The obtained genome assemblies, available on the GISAD database and performed at the Referral Center for COVID-19 diagnosis, identified 2 main monophyletic clades, containing 9 and 52 isolates, respectively.
The molecular clock analysis estimated a clusters divergence approximately one month before the first patient identification, supporting the hypothesis that different SARS-CoV-2 strains spread all over the world at different time, but their presence became evident only in late February along with Italian epidemic emergence.
Therefore, the epidemiological reconstruction carried out by this work highlights multiple inputs of the virus into its initial circulation in Lombardy Region.
However, a phylogenetic reconstruction robustness will be improved when other genomic sequences will be available, in order to guarantee a complete epidemiological surveillance.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
no external funding was received
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
All data used in the study were previously made anonymous, according to the requirements set by Italian Data Protection Code (Legislative Decree 196/2003) and the general authorizations issued by the Data Protection Authority. Under Italian law, all sensitive data were deleted and only age, gender and sampling date were collected providing Ethics Committee approval unnecessary (Art. 6 and Art. 9 of Legislative Decree 211/2003).
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
3 The members of the working group are listed at the end of the article
↵4 On behalf of Laboratory of Clinical Microbiology, Virology and Diagnostic of Bioemergencies group, Members of this group are listed as follows:
Rizzo Alberto
Giacomel Giovanni
Curreli Daniele
Cappelletti Cristina
Zanchetta Nadia
Grande Romualdo
Grosso Silvia Nella Faustina
Longo Margherita Olga Saveria
Lanzafame Salvatore Maria Giovanni
Longobardi Concetta
Calvagna Annunziata
Bosari Raffaella
Maresca Mafalda
Caliano Rosanna
Banfi Daniela
Tonielli Claudia
Bossi Carla
Fiori Lorenza
Tamoni Alessandro
Secchi Daniela
Pontoriero Cecilia
Dichirico Rita Barbara
Bertulli Manuela
Legnani Sara
Loiacono Aurelia
Terron Enrica
Dipaola Agata
Razzitti Vittoria Paola
Data Availability
SARS-COV-2 sequences are submitted to GISAID; we are waiting for the sequence numbers